|Day Low/High||7.06 / 7.49|
|52 Wk Low/High||4.73 / 33.83|
RECOVER study designed to understand the long-term clinical, environmental and socio-economic outcomes of SUBLOCADE treated individuals
- Projects full year 2018 revenues over $67 million, exceeding expectations, and projects end-of-year cash and cash equivalents in the range of $58 million to $60 million
Indivior PLC Announces Plan for Commercial Launch in February 2019 with 50 Sales Representatives
SLOUGH, England, Dec. 12, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that the U.
SLOUGH, England, Nov. 27, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that in light of the recent decision by the Court of Appeals for the Federal Circuit (CAFC) vacating the preliminary injunction against...
SUBLOCADE is the first and only once-monthly injectable buprenorphine formulation approved in Canada for the management of moderate to severe opioid use disorder SLOUGH, England and RICHMOND, Va.
-Company will continue to defend its intellectual property and implement contingency plan
PERSERIS delivers risperidone in a new once-monthly extended-release delivery system. Neither a loading dose nor any supplemental oral risperidone is recommended.
SLOUGH, United Kingdom and RICHMOND, Va., Nov.
Act Broadens Access to Medication-Assisted Treatment for People Affected by Opioid Addiction
This announcement contains inside information.
SLOUGH, England and RICHMOND, Va., Sept.
Milestone payment triggered by NDA approval of PERSERIS™ (risperidone)
The U.S. opioid crisis rages on. TheStreet takes a look at several drugs being used to help treat people.
The FTSE 250 pharmaceutical company said the U.S. District Court in Delaware has found that claims of a proposed generic version of Indivior's opioid addiction treatment by Dr. Reddy's does not infringe patents.
Société Générale, Deutsche Bank among biggest losers.
Indivior shares drop 16% in London on news of the lawsuit.
Semiconductor industry player ASML falls on reported snub from Intel.
U.S. futures point to markets opening in the red.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.